|Search for content and authors
A novel synthesis of 19-nor analogs of vitamin D
|Anita Pietraszek , Michał Chodyński , Agnieszka Ciesielska , Krzysztof Krajewski , Małgorzata Krupa , Marek Kubiszewski , Jerzy Winiarski , Andrzej Kutner
Instytut Farmaceutyczny (PRI), Rydygiera 8, Warszawa 01-793, Poland
In our continous search for new vitamin D analogs of therapeutic potential in hyperproliferative diseases we have synthesized a new series of analogs of 25-hydroxy vitamin D with truncated methylene unit at carbon atom C-10. The resulting new 19-nor vitamins D are analogous to the existing therapeutic agent from this group. Known syntheses of 19-nor analogs started from 25-hydroxy vitamin D2 or from quinic acid. However, these syntheses were designed to prepare a selected single analog and did not allowed for the preparation of a series of structurally related compounds to be used for structure-activity analysis. In addition, 25-hydroxy vitamin D2 is practically unavailable from commercial sources. Our retro-synthetic analysis showed that the target molecule might be conveniently constructed from 19-nor-A-ring synthon, CD-ring system and a side-chain fragment. In our approach the A-ring synthon is first coupled with the indane CD-ring system and then connected with variety of side-chain fragments. This way a series of side-chain modified analogs of 19-nor vitamins D might be obtained in a convergent manner. The yields of key synthetic steps allowed for the synthesis of selected analogs in preparative quantities. Our initial approach of combining first the CD-ring system with the respective side-chain fragment did not gave the intermediates in a yield high enough as for synthesis of potential pharmaceutical substances. The structure of new key intermediates: the CD-ring synthon and the ACD synthon was confirmed by spectroscopic and diffraction methods. The phosphine oxide of A-ring synthon was synthesized from the respective alcohol. This was prepared from an achiral precursor, 1,3,5-trihydroxybenzene. CD-Ring synthon was synthesized by a photolytic degradation of the commercial vitamin D2. The key diol SCD-2 was converted into the new ketosulfone - synthon CD. Wittig-Horner condensation of this synthon with the A-ring synthon gave the new 19-nor synthon ACD, as the advanced key intermediate. Julia olefination of this synthon with the side-chain aldehydes, followed by dehydroxy-desulfonylation and desilylatioin gave a series of target 19-nor analogs with various alkyls at C-26, C-27 and C-28. New analogs are screened for their cell differentiation and calcemic activity.
Presentation: Poster at VII Multidyscyplinarna Konferencja Nauki o Leku, by Anita Pietraszek
See On-line Journal of VII Multidyscyplinarna Konferencja Nauki o Leku
Submitted: 2010-03-10 08:27 Revised: 2010-03-10 08:27